Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK501636PMID: 30000697
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 49562-28-9
Drug Levels and Effects
Summary of Use during Lactation
No relevant published information exists on the use of fenofibrate during breastfeeding. Because of a concern with disruption of infant lipid metabolism, fenofibrate is best avoided during breastfeeding. An alternate drug is preferred, especially while nursing a newborn or preterm infant. The manufacturer recommends that breastfeeding be avoided during fenofibrate therapy and for 5 days after the final dose.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Fenofibrate
CAS Registry Number
49562-28-9
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Ethacrynic Acid.[Drugs and Lactation Database (...]Review Ethacrynic Acid.. Drugs and Lactation Database (LactMed®). 2006
- Review Gemfibrozil.[Drugs and Lactation Database (...]Review Gemfibrozil.. Drugs and Lactation Database (LactMed®). 2006
- Lipid-lowering drugs.[Med Lett Drugs Ther. 2019]Lipid-lowering drugs.. Med Lett Drugs Ther. 2019 Feb 11; 61(1565):17-24.
- Review Indomethacin.[Drugs and Lactation Database (...]Review Indomethacin.. Drugs and Lactation Database (LactMed®). 2006
- Comparison table: Some lipid-lowering drugs.[Med Lett Drugs Ther. 2022]Comparison table: Some lipid-lowering drugs.. Med Lett Drugs Ther. 2022 Sep 19; 64(1659):e152-e158. Epub 2022 Sep 19.
- Fenofibrate - Drugs and Lactation Database (LactMed®)Fenofibrate - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...